Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer HealthcarefiledCriticalBayer Healthcare
Priority to UY28628ApriorityCriticalpatent/UY28628A1/en
Publication of UY28628A1publicationCriticalpatent/UY28628A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a un procedimiento para la preparación de una composición far,acéutica sólida administrable oralmente que contiene 5-cloro-N-(((5S)-2-oxo-3-(4(3-oxo-4-morfolinil)-fenil)-1,3-oxazolidin-5-il)-metil)-2-tiofencarboxamida en forma hidrofilizada así como a su uso para la profilaxis y/o tratamiento de enfermedades.The present invention relates to a process for the preparation of a solid, orally administrable solid, far-chemical composition containing 5-chloro-N - (((5S) -2-oxo-3- (4 (3-oxo-4-morpholinyl) ) -phenyl) -1,3-oxazolidin-5-yl) -methyl) -2-thiophenecarboxamide in hydrophilized form as well as its use for the prophylaxis and / or treatment of diseases.
UY28628A2004-11-232004-11-23
PROCEDURE FOR THE PREPARATION OF AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL COMPOSITION
UY28628A1
(en)
NEW POLYMORPHIC FORM AND THE AMORPHY FORM OF 5-CHLORINE-N - ({(5S) -2-OXO-3- [4- (3-OXO-4-MORFOLINIL) -FENIL] -1,3-OXAZOLIDIN-5- IL} -METIL) -2-THIOPHENOCARBOXAMIDE
Crystalline form of 5- [3- (2,5-dichloro-4,6-dimethyl-1-oxy-pyridin-3-yl) - [1,2,4] oxadiazol-5-yl] -3-nitrobenzene- 1,2-diol, a pharmaceutical composition that comprises it, a process to obtain it and its use to treat mood disorders, Parkinson's disease and Parkinsonian disorders, gastrointestinal disorders, among others.
PROCEDURE FOR THE PREPARATION OF A SOLID ADMINISTRABLE PHARMACEUTICAL COMPOSITION ORALALLY INCLUDING 5-CHLORINE-N - ({(5S) -2-OXO-3- [4- (3-OXO-4-MORFOLINIL) -FENIL] -1,3 -OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE IN HYDROPHILIZED FORM